 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper129th MAINE LEGISLATURE
FIRST REGULAR SESSION-2019
Legislative Document No. 266
S.P. 78 In Senate,  January  22, 2019
An Act  To Eliminate the  2-year Limit on MaineCare Coverage  for 
Approved Drugs for Opioid  Use Disorder
Reference to the Committee on Health  and Human Services suggested and  ordered printed.
DAREK M.  GRANT
Secretary of the Senate
Presented by Senator SANBORN,  L. of Cumberland.
Cosponsored by Representative HYMANSON  of York  and
Senators: CLAXTON of Androscoggin, GRATWICK of Penobscot,  MOORE of Washington,  
Representative: PERRY of Calais.

Page 1 - 129LR1527(01)-11Be it enacted by the People of the State of Maine as follows:
2Sec. 1.  22 MRSA §3174-SS, as enacted by PL 2011, c. 477, Pt. I, §1, is repealed.
3Sec. 2.  22 MRSA §3174-UU, sub-§7, ¶D, as amended by PL 2013, c. 368, Pt. 
4AAAAA, §1, is further amended to read:
5D.  A MaineCare member for whom MaineCare reimbursement for opioid drugs for 
6the treatment of addiction is restricted by limits applicable to methadone and a 
7MaineCare member who is receiving buprenorphine and naloxone combination drugs 
8for the treatment of addiction; and
9SUMMARY
10This bill repeals the 24-month limit on MaineCare coverage or reimbursement for 
11buprenorphine and naloxone combination drugs, also known as Suboxone, for the 
12treatment of addiction to opioids.
